Periodic Reporting for period 1 - VEMOtion (Assistive Medical Robotics for Very Early Mobilization of Critical Care Patients)
Okres sprawozdawczy: 2023-01-01 do 2023-12-31
currently performed with only 25% of ICU patients due to lack of resources and hazardous nature of the manual procedure. Reactive Robotics has developed VEMOTION, the world’s first AI-driven robotic assistance system for early mobilisation in ICUs. VEMOTION enables the clinically proven benefits of early mobilisation to be delivered safely to all ICU patients, accelerating recovery by 20%, reducing treatment costs, increasing ICU capacity by 27%, and improving patient outcomes. Introduction creates a >€5bn market for ICU robotics. The EIC project (€2.5M grant, €15M equity) delivers crucial product development and large-scale clinical trials to validate the clinical/business case and accelerate scale-up.
Significant achievements of the project include the successful certification for bariatric patients, the optimization of patient adapters which connect the patient with the robot: for instance, a one-size-fits-all Leg Adapter was already successful introduced into the market.
Further key activities comprise the successful development of prototypes for a new embedded control system and a hospital bed platforms that will optimise the interaction between the bed and robot and enable functions that are in high demand on the market. Moreover, a prototype of a revised graphical user interface that facilitates time-optimized workflows has been developed. Additionally, the project achieved an upgrade of the underlying data warehouse, incorporating analysis tools for service and maintenance purposes. These accomplishments collectively contribute to the overall improvement of the system's performance and user experience.
To strengthen the clinical data case, two suitable KOLs were identified in two different German hospitals. With the first partner (patient population: pulmonological), a contract for a small clinical trial was signed, and the study protocol was created and submitted. The ramp-in phase has already started. With the second partner (patient population: neurological), a first draft of the study protocol was defined, and administrative topics are now being finalized.